Oramed Pharmaceuticals Inc. (ORMP): Shareholders' Equity
$199.74M
As of 2025-12-31
+9.6%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $199.74M | +36.6% | 2026-03-26, Balance as of period end |
| 2024-12-31 | $146.26M | -10.7% | 2026-03-26, Balance as of period end |
| 2023-12-31 | $163.82M | +7.9% | 2025-03-27, Balance as of period end |
| 2022-12-31 | $151.81M | -8.8% | 2024-03-06, Balance as of period end |
| 2021-12-31 | $166.45M | n/a | 2023-03-06, Balance as of period end |
| 2021-08-31 | $115.77M | +252.1% | 2021-11-24, Balance as of period end |
| 2020-08-31 | $32.88M | +69.5% | 2021-11-24, Balance as of period end |
| 2019-08-31 | $19.39M | -37.7% | 2020-11-24, Balance as of period end |
| 2018-08-31 | $31.11M | +61.7% | 2019-11-27, Balance as of period end |
| 2017-08-31 | $19.24M | -26.5% | 2019-11-27, Balance as of period end |
| 2016-08-31 | $26.19M | +5.5% | 2018-11-28, Balance as of period end |
| 2015-08-31 | $24.83M | +19.4% | 2017-11-29, Balance as of period end |
| 2014-08-31 | $20.79M | +155.7% | 2016-11-25, Balance as of period end |
| 2013-08-31 | $8.13M | +115.2% | 2015-11-25, Balance as of period end |
| 2012-08-31 | $3.78M | +1.5% | 2014-11-14, Balance as of period end |
| 2011-08-31 | $3.72M | +348.5% | 2013-11-27, Balance as of period end |
| 2010-08-31 | $830.3K | -69.8% | 2013-11-27, Balance as of period end |
| 2009-08-31 | $2.75M | -40.2% | 2013-11-27, Balance as of period end |
| 2008-08-31 | $4.59M | +795.1% | 2013-11-27, Balance as of period end |
| 2007-08-31 | $513.1K | n/a | 2013-11-27, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | 2025-12-31 | $199.74M | +36.6% |
| Immuneering Corp (IMRX) | 2025-12-31 | $218.48M | +427.9% |
| Design Therapeutics, Inc. (DSGN) | 2025-12-31 | $212.50M | -12.2% |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$23.11M | n/m |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | $181.21M | -40.4% |
| Evommune, Inc. (EVMN) | 2025-12-31 | $205.57M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $1.34M | -88.2% |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $203.01M | n/m |
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | $159.22M | +261.6% |
Compare ORMP, IMRX, DSGN, EOLS side by side · Screen every company in Pharmaceutical Preparations ↗